MedPath

江苏东科康德药业有限公司

Ownership
-
Established
2021-06-15
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Lenvatinib Mesilate Capsules

Product Name
甲磺酸仑伐替尼胶囊
Approval Number
国药准字H20253427
Approval Date
Feb 20, 2025
NMPA

Phloroglucinol Injection

Product Name
间苯三酚注射液
Approval Number
国药准字H20253420
Approval Date
Feb 20, 2025
NMPA

Epalrestat Tablets

Product Name
依帕司他片
Approval Number
国药准字H20253176
Approval Date
Jan 14, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.